Le Lézard
Classified in: Science and technology
Subjects: Conference, Product/Service, Trade Show

Henry Schein Announces Lineup of New Products, Software, and Equipment at the Greater New York Dental Meeting


Henry Schein, Inc. (Nasdaq: HSIC) today announced its presence at the 2022 Greater New York Dental Meeting (GNYDM), featuring an expansive lineup of products and solutions designed to help oral health professionals enhance practice efficiency and the patient experience.

Visitors to the GNYDM can explore the Company's comprehensive portfolio of products, services, and solutions that help optimize every step of the practice workflow, including:

"We are excited to connect with the dental community and discuss exciting new trends during this year's Greater New York Dental Meeting," said Dave Steck, Vice President and General Manager, U.S. Dental Group, Henry Schein. "Henry Schein continues to be laser-focused on providing the best possible customer experience, creating synergies with our supply chain, equipment sales and service, and other value-added solutions so our customers can leverage the combined value we offer."

Digital Solutions to Enhance Practice Efficiency

Throughout the meeting, Henry Schein will demonstrate the latest products and digital technology solutions, including lasers, scanners, and 3D printers. Members of the Henry Schein Dental leadership team, along with representatives from 3Shape, ACTEON, A-dec, Convergent Dental, Digital Doc, enBio, Medit, Planmeca, and SprintRay will be available to answer questions, suggest customized solutions, and demonstrate new products, such as:

Optimizing Practice Management

Visitors to Henry Schein One's booth can explore the Company's portfolio of solutions all designed to enhance the practice workflow, including:

Henry Schein One will also launch Dentrix® Detect AI powered and manufactured by VideaHealth, an AI enabled X-ray analysis tool that provides real-time clinical decision support to dentists. Its full integration into Dentrix allows it to work within existing Dentrix workflows and eliminates the need for dentists to import or export images to utilize AI analysis. Every image is automatically analyzed in the software, helping dentists more quickly evaluate radiographs and other images. As a result, dentists can provide greater transparency to patients, making treatment recommendations chairside and helping to improve case acceptance.

To learn more about Henry Schein's presence at this year's GNYDM, please visit https://henryscheinevents.com/.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: